The Patent Finder
US

Nucleotide Hemi-Sulfate Salt for the Treatment of Hepatitis C Virus

US 12,006,340 In force
OverviewFamilyAssignmentsSources & methods
Collateral for a security interest recorded Nov 6, 2026 (Hercules Capital, Inc.).

Term ends Jan 31, 2038 · Medium confidence

Why Medium: A parent in the chain could not be resolved.

Filed Jan 23, 2023 as application 18/100,448 · Granted Jun 11, 2024
Base term, 20 years from filing
Today
20 years from filing
2018 2038
Clock starts
Jan 31, 2018
Term ends
Jan 31, 2038
Granted
Jun 11, 2024
base term Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
0 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
7
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. 0 of 3 maintenance fees are paid so far. Confidence: Medium. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Jan 31, 2018, when application 15/885,630, the earliest non-provisional in its chain, was filed (this one was filed Jan 23, 2023); a parent in its chain could not be resolved (the next row)Jan 31, 2038High confidence
Continuity chainA parent in the chain could not be resolveddated from this application's own claimMedium confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events0 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderJan 31, 2038Medium confidence

This family

US 10,519,186In force
Apr 2038
Apr 2038
US 10,906,928In force
Jan 2038
Jan 2038
US 10,894,804In force
Jan 2038
Jan 2038
Application 17/118,314Abandoned
not computed
not computed
Application 17/306,659Abandoned
not computed
not computed
US 12,006,340this patent
Jan 2038
Jan 2038
US 12,741,984In force
Jan 2038
Jan 2038
The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Jan 22, 2024
Reel 66202, frame 10
Moussa, Adel; Sommadossi, Jean-pierreAtea Pharmaceuticals, Inc.Assignment of Assignor's Interest
Nov 6, 2026
Reel 76664, frame 870
Atea Pharmaceuticals, Inc.Hercules Capital, Inc., as AgentSecurity Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited